{
  "meta": {
    "title": "14_Previous_Year_Questions",
    "url": "https://brainandscalpel.vercel.app/14-previous-year-questions-26cafc89.html",
    "scrapedAt": "2025-11-30T18:17:49.469Z"
  },
  "questions": [
    {
      "text": "Mental Health Gap Action Programme (mhGAP) includes all of the following disorders except?",
      "choices": [
        {
          "id": 0,
          "text": "OCD"
        },
        {
          "id": 1,
          "text": "Depression"
        },
        {
          "id": 2,
          "text": "Schizophrenia"
        },
        {
          "id": 3,
          "text": "Childhood mental disorder"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct Option A - OCD:</strong></p>\n\n<ul>\n\t<li>The Mental Health Gap Action Programme by¬†WHO does not prioritize <span class=\"customMeta\" data-dictid=\"eb72e1abf016927771943ccc05db73\">Obsessive-Compulsive</span> Disorder (OCD) for intervention due to its relatively lower <span class=\"customMeta\" data-dictid=\"f86aae0bd61692777196f91458c9dd\">prevalence</span> and burden compared to other disorders.</li>\n</ul>\n\n<p>¬†</p>\n\n<p><strong>Incorrect Options:</strong></p>\n\n<p><strong>Option B - Depression: </strong>Included in mhGAP as it is a major contributor to the global burden of disease.</p>\n\n<p><strong>Option C - Schizophrenia: </strong>Included due to its significant impact on individuals and healthcare systems.</p>\n\n<p><strong>Option D - Childhood mental disorder: </strong>Included to address the early onset and potential long-term consequences of these disorders.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Supportive therapy can be given for all of the following candidates except?",
      "choices": [
        {
          "id": 0,
          "text": "Person who is severely ill and is not cooperative"
        },
        {
          "id": 1,
          "text": "Person who is motivated and has no control over frustration"
        },
        {
          "id": 2,
          "text": "Person with cognitive and functional deficit"
        },
        {
          "id": 3,
          "text": "Person who is severely ill and has lost his ego function."
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Correct Option B - Person who is motivated and has no control on frustration:</strong></p>\n\n<ul>\n\t<li>Supportive therapy is less effective for individuals who are unable to control their frustration because they may not be able to engage productively in the <span class=\"customMeta\" data-dictid=\"8dfaeedbf91692777200561b2b1d2f\">therapeutic</span> process. Their frustration can hinder the development of a <span class=\"customMeta\" data-dictid=\"8dfaeedbf91692777200561b2b1d2f\">therapeutic</span> alliance and limit their ability to benefit from the support offered.</li>\n</ul>\n\n<p><strong>Incorrect Options:</strong></p>\n\n<p><strong>Option A - Person who is severely ill and is not cooperative: </strong>While challenging, supportive therapy can be adapted to gradually build cooperation and engage the patient over time<strong>.</strong></p>\n\n<p><strong>Option C - Person with cognitive and functional deficit: </strong>Supportive therapy can be tailored to address the needs of individuals with cognitive and functional deficits, providing practical support and adapting communication to their abilities.</p>\n\n<p><strong>Option D - Person who is severely ill and has lost his ego function: </strong>Supportive therapy can be beneficial even for severely ill individuals by providing a structured and supportive environment, although the approach may need to be highly specialized.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Cannabinoids are not used for which of the following conditions?",
      "choices": [
        {
          "id": 0,
          "text": "Dravet syndrome"
        },
        {
          "id": 1,
          "text": "Tuberous sclerosis complex"
        },
        {
          "id": 2,
          "text": "Lennox-Gastaut syndrome"
        },
        {
          "id": 3,
          "text": "Rett syndrome"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Correct Option D - Rett syndrome:</strong></p>\n\n<ul>\n\t<li>Cannabinoids are not typically used for Rett syndrome, a genetic disorder affecting brain development, resulting in severe cognitive and physical disabilities.</li>\n</ul>\n\n<p><strong>Incorrect Options:</strong></p>\n\n<p><strong>Option A - Dravet syndrome: </strong>Cannabinoids are approved for use in Dravet syndrome, a severe <span class=\"customMeta\" data-dictid=\"a1b06f401f1692777203a53393ba98\">form</span> of epilepsy, to help reduce the frequency of seizures.</p>\n\n<p><strong>Option B - <span class=\"customMeta\" data-dictid=\"93b7b2cfd31692777201efc538e5a2\">Tuberous</span> <span class=\"customMeta\" data-dictid=\"dae4dea0581692777198fdef9fa684\">sclerosis</span> complex: </strong>Cannabinoids are also used to treat seizures associated with the <span class=\"customMeta\" data-dictid=\"93b7b2cfd31692777201efc538e5a2\">tuberous</span> <span class=\"customMeta\" data-dictid=\"dae4dea0581692777198fdef9fa684\">sclerosis</span> complex, another genetic disorder that causes <span class=\"customMeta\" data-dictid=\"1bbae82f1f16927771824f797639fa\">benign</span> tumors to grow in the brain and other vital organs.</p>\n\n<p><strong>Option C - Lennox-Gastaut syndrome: </strong>Lennox-Gastaut syndrome, a severe <span class=\"customMeta\" data-dictid=\"eb8fb619d916927771879a8048d513\">epileptic</span> disorder in children, is another condition for which cannabinoids are an approved treatment to help manage seizures.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A patient with Alzheimer‚Äôs disease refused to take oral drugs. Which of the following drugs can be prescribed to this patient?",
      "choices": [
        {
          "id": 0,
          "text": "Memantine"
        },
        {
          "id": 1,
          "text": "Donepezil"
        },
        {
          "id": 2,
          "text": "Rivastigmine"
        },
        {
          "id": 3,
          "text": "Galantamine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct Answer C - Rivastigmine </strong></p>\n\n<ul>\n\t<li>In this scenario, a<strong> <span class=\"customMeta\" data-dictid=\"48982b740216927772004a198271cd\">transdermal</span> Rivastigmine patch </strong>can be used as an alternative, as it is the only option available in India.</li>\n\t<li>It is a <span class=\"customMeta\" data-dictid=\"a4488d66fc16927771975d043c4ccc\">reversible</span> <span class=\"customMeta\" data-dictid=\"16b654488116927771813c39bf19e7\">anticholinesterase</span> used in the treatment of Alzheimer's disease.</li>\n\t<li>It is also available as a <span class=\"customMeta\" data-dictid=\"48982b740216927772004a198271cd\">transdermal</span> patch, which is applied to the skin and releases the medication gradually over 24 hours, ensuring a steady and continuous <span class=\"customMeta\" data-dictid=\"8dfaeedbf91692777200561b2b1d2f\">therapeutic</span> effect.</li>\n</ul>\n\n<p><strong>Treatment of Alzheimer‚Äôs disease</strong></p>\n\n<ul>\n\t<li>Patient and caregiver education.</li>\n\t<li><strong>Neurotransmitter-based therapies</strong>\n\t<ul>\n\t\t<li>Acetylcholinesterase inhibitors\n\t\t<ul>\n\t\t\t<li>Donepezil</li>\n\t\t\t<li>Rivastigmine</li>\n\t\t\t<li>Galantamine</li>\n\t\t</ul>\n\t\t</li>\n\t\t<li>N-methyl-d-aspartate (NMDA) <span class=\"customMeta\" data-dictid=\"ada5fcf7e416927771886ff24152ff\">glutamate</span> <span class=\"customMeta\" data-dictid=\"9e4959f6f316927771978bb152d440\">receptor</span> blocker\n\t\t<ul>\n\t\t\t<li>Memantine</li>\n\t\t</ul>\n\t\t</li>\n\t\t<li>A common approach to AD drug therapy is to initiate a <span class=\"customMeta\" data-dictid=\"aefa9aaa9216927771841998c2c30a\">cholinesterase</span> <span class=\"customMeta\" data-dictid=\"b5fb56a28b1692777190396ae8b625\">inhibitor</span> for a patient diagnosed with mild AD <span class=\"customMeta\" data-dictid=\"41cc5ad93c169277718553c6b948a3\">dementia</span> and to add memantine when patients enter the moderate stage of the disease.</li>\n\t</ul>\n\t</li>\n\t<li><strong>Therapies <span class=\"customMeta\" data-dictid=\"e4865847fa169277720044d7b530b0\">targeting</span> amyloid-ùõÉ</strong>\n\t<ul>\n\t\t<li><strong>Aducanumab</strong>\n\t\t<ul>\n\t\t\t<li>MOA: <span class=\"customMeta\" data-dictid=\"b2b82438d6169277719287eb450079\">Monoclonal</span> <span class=\"customMeta\" data-dictid=\"9d7a12cab116927771811a0079086d\">antibody</span> <span class=\"customMeta\" data-dictid=\"e4865847fa169277720044d7b530b0\">targeting</span> the N-terminus of the AŒ≤ peptide</li>\n\t\t\t<li>Dosage: <span class=\"customMeta\" data-dictid=\"27b78a96071692777190f4dfb93430\">Intravenous</span> <span class=\"customMeta\" data-dictid=\"3562d699c516927771909a426ea8ef\">infusion</span> every 4 weeks (7 infusions in total)</li>\n\t\t\t<li><strong>Should only be considered for treating <span class=\"customMeta\" data-dictid=\"dab50a711a169277719245a7e8dc11\">MCI</span> (Mild Cognitive Impairment) or early <span class=\"customMeta\" data-dictid=\"41cc5ad93c169277718553c6b948a3\">dementia</span> due to AD </strong></li>\n\t\t\t<li>S/E: <span class=\"customMeta\" data-dictid=\"c8013ecf46169277720128cab0a7b4\">Vasogenic</span> cerebral edema, <span class=\"customMeta\" data-dictid=\"721937292f1692777185048f04ce29\">cortical</span> microhemorrhages, and <span class=\"customMeta\" data-dictid=\"ebb480187d1692777199e233e9e356\">superficial</span> siderosis</li>\n\t\t</ul>\n\t\t</li>\n\t</ul>\n\t</li>\n</ul>\n\n<p><strong>Memantine (Option A)</strong>,<strong> </strong>an <span class=\"customMeta\" data-dictid=\"000b76a37716927771932ba41c5089\">NMDA</span> <span class=\"customMeta\" data-dictid=\"2e432a4f3c1692777181e8e244ca0e\">antagonist</span> for moderate to severe Alzheimer's, regulates <span class=\"customMeta\" data-dictid=\"ada5fcf7e416927771886ff24152ff\">glutamate</span> and is given orally. Treatment typically starts with a <span class=\"customMeta\" data-dictid=\"aefa9aaa9216927771841998c2c30a\">cholinesterase</span> <span class=\"customMeta\" data-dictid=\"b5fb56a28b1692777190396ae8b625\">inhibitor</span> for mild AD and adds memantine in the moderate stage, but it is only available in oral form.</p>\n\n<p><strong>Donepezil (Option B) </strong>and <strong>Galantamine (Option D)</strong> are <span class=\"customMeta\" data-dictid=\"a4488d66fc16927771975d043c4ccc\">reversible</span> <span class=\"customMeta\" data-dictid=\"16b654488116927771813c39bf19e7\">anticholinesterase</span> inhibitors used to treat mild to moderate Alzheimer's disease. While they are available in both oral and <span class=\"customMeta\" data-dictid=\"48982b740216927772004a198271cd\">transdermal</span> patch forms, only the oral forms are accessible in India, making them incorrect options.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "What was the intended function of thiopentone and succinylcholine given to a patient receiving ECT treatment for severe depression?",
      "choices": [
        {
          "id": 0,
          "text": "To bring a calming effect"
        },
        {
          "id": 1,
          "text": "To produce mood elevation"
        },
        {
          "id": 2,
          "text": "To induce anesthesia and relax muscles"
        },
        {
          "id": 3,
          "text": "To prevent memory loss after the ECT"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct Answer C - To induce <span class=\"customMeta\" data-dictid=\"e24b7bd55d16927771818aaa6ad0ed\">anesthesia</span> and relax muscles</strong></p>\n\n<ul>\n\t<li><strong>Electroconvulsive therapy (ECT) </strong>is a procedure used to treat severe depression, and it involves the administration of a general anaesthetic and a muscle relaxant.</li>\n\t<li><strong>Thiopentone </strong>is an ultra-short-acting <span class=\"customMeta\" data-dictid=\"8815b1ff5b1692777182be93e820b0\">barbiturate</span> that is used to induce anaesthesia, and Succinylcholine is a depolarising <span class=\"customMeta\" data-dictid=\"9d07b67b5f1692777193d48329a32a\">muscle relaxant</span> that helps to prevent convulsions during the procedure.</li>\n\t<li>However<strong>, <span class=\"customMeta\" data-dictid=\"4917fcff2e1692777192588ec8094e\">methohexital</span> </strong>is the most commonly used anaesthetic because of its lower likelihood of <span class=\"customMeta\" data-dictid=\"b20624b08216927771961a650a498e\">postictal</span> arrhythmias and shorter duration of action.</li>\n</ul>\n\n<p><strong>To bring a calming effect</strong> <strong>(Option A)</strong>: The purpose of <span class=\"customMeta\" data-dictid=\"f999d172b91692777186778c4e5593\">ECT</span> is not to sedate or calm the patient but to induce a controlled <span class=\"customMeta\" data-dictid=\"5710e3461816927771987151d61aef\">seizure</span> in the brain for <span class=\"customMeta\" data-dictid=\"8dfaeedbf91692777200561b2b1d2f\">therapeutic</span> effects.</p>\n\n<p><strong>To produce mood <span class=\"customMeta\" data-dictid=\"a1f256489a16927771870ddd296574\">elevation</span> (Option B)</strong>: The primary goal of <span class=\"customMeta\" data-dictid=\"f999d172b91692777186778c4e5593\">ECT</span> is to treat severe psychiatric conditions (like depression, mania, or catatonia) by using controlled seizures to induce neurochemical changes that help improve the patient's mood over time. However, mood <span class=\"customMeta\" data-dictid=\"a1f256489a16927771870ddd296574\">elevation</span> is not the primary effect. <strong> </strong></p>\n\n<p><strong>To prevent memory loss</strong> <strong>(Option D)</strong>: The medications used during <span class=\"customMeta\" data-dictid=\"f999d172b91692777186778c4e5593\">ECT</span> are not intended to prevent memory loss. These drugs serve to <strong>induce anaesthesia</strong> and <strong>relax muscles</strong>, which help the patient remain <span class=\"customMeta\" data-dictid=\"6d87fbc02c16927772014ec4cead53\">unconscious</span> and prevent muscle contractions during the <span class=\"customMeta\" data-dictid=\"f3063c1d8b169277719018bf869980\">induced</span> seizure.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which statement most accurately characterizes paradoxical suicide?",
      "choices": [
        {
          "id": 0,
          "text": "Suicide occurring at the time when the patient starts to recover"
        },
        {
          "id": 1,
          "text": "Suicide after taking low dose of drug"
        },
        {
          "id": 2,
          "text": "Accidental completion of suicide"
        },
        {
          "id": 3,
          "text": "None of the above"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct Option</strong>:</p>\n\n<p><strong>Option A: </strong>Suicide occurring at the time when the patient starts to recover.</p>\n\n<p>Paradoxical suicide refers to a phenomenon where individuals take their own lives at a time when they appear to be improving or showing signs of recovery from a mental health condition. It is characterized by a sudden and unexpected act of suicide despite the apparent improvement in the person's mental state or circumstances.</p>\n\n<p>¬†</p>\n\n<p><strong>Incorrect Options:</strong></p>\n\n<p><strong>Option B:</strong> Suicide after taking a low dose of drug: This does not describe <span class=\"customMeta\" data-dictid=\"5b09a1161b169277719460978e4cc1\">paradoxical</span> suicide specifically. The <span class=\"customMeta\" data-dictid=\"b5bd69c9791692777186a40f45ffb6\">dosage</span> of the drug is not a defining factor in <span class=\"customMeta\" data-dictid=\"5b09a1161b169277719460978e4cc1\">paradoxical</span> suicide.</p>\n\n<p><strong>Option</strong> <strong>C</strong>: <span class=\"customMeta\" data-dictid=\"fb7ff97e071692777180252299cf10\">Accidental</span> completion of suicide: <span class=\"customMeta\" data-dictid=\"5b09a1161b169277719460978e4cc1\">Paradoxical</span> suicide is not <span class=\"customMeta\" data-dictid=\"fb7ff97e071692777180252299cf10\">accidental</span> but rather a deliberate act.</p>\n\n<p><strong>Option D</strong>: None of the above: This is an incorrect option as option A accurately describes <span class=\"customMeta\" data-dictid=\"5b09a1161b169277719460978e4cc1\">paradoxical</span> suicide.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Under the Mental Health Care Act 2017, a patient has the right to choose his or her caretaker and future course of action in treatment. What is this provision known as?",
      "choices": [
        {
          "id": 0,
          "text": "Treatment directive"
        },
        {
          "id": 1,
          "text": "Mental will"
        },
        {
          "id": 2,
          "text": "Future directive"
        },
        {
          "id": 3,
          "text": "Advance directive"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Correct Option D:¬†</strong></p>\n\n<ul>\n\t<li>Advance directive: The provision mentioned in the question is known as an \"advance directive.\" An <span class=\"customMeta\" data-dictid=\"a7ad3beb9b16927771800c0751317c\">advance directive</span> is a legal document that allows individuals to specify their preferences regarding medical or mental health treatment in the future, particularly if they become incapable of making decisions at that time. It empowers individuals to express their wishes regarding treatment, including choosing a caretaker or outlining their desired course of action. Advance directives are meant to ensure that an individual's autonomy and preferences are respected and followed in the event of incapacity.</li>\n</ul>\n\n<p><strong>Incorrect Options:¬†</strong></p>\n\n<p><strong>Option A</strong>-Treatment directive: A treatment directive is a legal document that outlines a person's preferences for medical treatment in the event they become unable to make decisions for themselves. However, this term is not specifically associated with the Mental Health Care Act 2017.</p>\n\n<p><strong>Option B</strong>-Mental will: \"Mental will\" is not a commonly used term or provision in the context of mental health legislation or the right to choose a caretaker and future course of action in treatment.</p>\n\n<p><strong>Option C</strong>-Future directive: \"Future directive\" is a general term that could refer to a range of legal documents or provisions related to specifying preferences or instructions for future medical or mental health treatment. However, it is not a specific term associated with the Mental Health Care Act 2017.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    }
  ]
}